Journal
RHEUMATOLOGY
Volume 53, Issue 5, Pages 777-784Publisher
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/ket319
Keywords
skin microbiome; psoriatic arthritis; next-generation sequencing; metagenomics
Categories
Funding
- National Institute for Health Research Manchester Musculoskeletal Biomedical Research Unit Fellowship Award
- Arthritis Research UK [20385]
- Eli Lilly
- Pfizer
- Abbvie
- Amgen
- Wyeth/Pfizer
Ask authors/readers for more resources
The resident microbial community, harboured by humans in sites such as the skin and gastrointestinal tract, is enormous, representing a candidate environmental factor affecting susceptibility to complex diseases, where both genetic and environmental risk factors are important. The potential of microorganisms to influence the human immune system is considerable, given their ubiquity. The impact of the host-gene-microbe interaction on the maintenance of health and the development of disease has not yet been assessed robustly in chronic inflammatory conditions. PsA represents a model inflammatory disease to explore the role of the microbiome because skin involvement and overlap with IBD implicates both the skin and gastrointestinal tract as sources of microbial triggers for PsA. In parallel with genetic studies, characterization of the host microbiota may benefit our understanding of the microbial contribution to disease pathogenesis-knowledge that may eventually inform the development of novel therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available